Cytoimmune Therapeutics has a total of 68 patents globally, out of which 5 have been granted. Of these 68 patents, more than 60% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cytoimmune Therapeutics.
Cytoimmune Therapeutics was founded in the year 2019. The Company develops novel, coordinated immunotherapy solutions for patients. Their CoalesceNT platform harnesses the power of bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to coordinate an immune response with both natural killer (NK) and T cells.
Do read about some of the most popular patents of Cytoimmune Therapeutics which have been covered by us in this article and also you can find Cytoimmune Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cytoimmune Therapeutics patent portfolio.
How many patents does the founder and the CEO of Cytoimmune Therapeutics have?
The founder Michael A. Caligiuri has 0 patent and William Rosellini has 0 patent and CEO Jose Eduardo Vidal has 0 patent.
How many patents does Cytoimmune Therapeutics have?
Cytoimmune Therapeutics has a total of 68 patents globally. These patents belong to 12 unique patent families. Out of 68 patents, 60 patents are active.
How Many Patents did Cytoimmune Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Cytoimmune Therapeutics Applications Filed | Cytoimmune Therapeutics Patents Granted |
| 2022 | 7 | 1 |
| 2021 | 22 | 3 |
| 2020 | 12 | 1 |
| 2019 | 18 | – |
| 2017 | 1 | – |
| 2016 | 8 | – |
How many Cytoimmune Therapeutics patents are Alive/Dead?
How Many Patents did Cytoimmune Therapeutics File in Different Countries?
Countries in which Cytoimmune Therapeutics Filed Patents
| Country | Patents |
| Australia | 8 |
| United States Of America | 8 |
| Europe | 8 |
| Canada | 5 |
| Japan | 4 |
| Singapore | 3 |
| Colombia | 3 |
| Taiwan | 3 |
| India | 3 |
| Hong Kong (S.A.R.) | 2 |
| Brazil | 2 |
| Israel | 2 |
| Mexico | 2 |
| Ecuador | 1 |
| Mongolia | 1 |
| Costa Rica | 1 |
| Indonesia | 1 |
| Viet Nam | 1 |
| Africa | 1 |
| South Africa | 1 |
| Papua New Guinea | 1 |
| Philippines | 1 |
Where are Research Centres of Cytoimmune Therapeutics Patents Located?
What Percentage of Cytoimmune Therapeutics US Patent Applications were Granted?
Cytoimmune Therapeutics (Excluding its subsidiaries) has filed 7 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Cytoimmune Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Cytoimmune Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Foley & Lardner Llp | 7 | 100.00% |
What are Cytoimmune Therapeutics key innovation segments?
What Technologies are Covered by Cytoimmune Therapeutics?
The chart below distributes patents filed by Cytoimmune Therapeutics